Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
GLP-1 receptor agon
>>
Phase 4
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
47
94
141
188
235
282
329
376
423
470
Victoza
(liraglutide) / Novo Nordisk
Ozempic
(semaglutide SC once-weekly) / Novo Nordisk
Byetta
(exenatide) / AstraZeneca
Rybelsus
(semaglutide oral) / Novo Nordisk
Trulicity
(dulaglutide) / Eli Lilly
Mounjaro
(tirzepatide) / Eli Lilly
Bydureon
(exenatide XR once-weekly) / AstraZeneca
Saxenda
(liraglutide 3 mg) / Novo Nordisk
Adlyxin
(lixisenatide) / Sanofi
Tanzeum
(albiglutide) / GSK
IDegLira
(insulin degludec/liraglutide) / Novo Nordisk
Fu Laimei
(polyethylene glycol loxenatide) / Jiangsu Hansoh Pharma
Soliqua 100/33
(lixisenatide/insulin glargine) / Sanofi
